Evaluation of the Achievement of a Pharmacodynamic Target of Piperacillin‐Tazobactam for the Population With Obesity: An Open Randomized Controlled Feasibility Study (TAZO‐OBESITY Trial)

Sabrina Larocque, Juliette Fournier, Justine Brasseur‐Masse, Britanny Bernard, Guiva Annane, Louis‐Patrick Haraoui, Anis Ouyahia, Amélie Marsot, Benoît Crevier
Fundamental and Clinical Pharmacology · Wiley · 2026-10-21 · DOI: 10.1111/fcp.70116

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles